Mylan Wins Backing of Top Holder Abbott to Avoid Takeover

Updated on

Mylan NV’s top shareholder is backing the drugmaker’s plan to avoid being taken over by its biggest rival in the generics industry.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.